Bone-Enhancing
Raloxifene Doesn't Increase "Hot Flashes"
Alternative
To HRT For Bone Strength Studied
For women looking
to stop hormone replacement therapy and switch instead to the bone-enhancing
drug Raloxifene, there is good news: You will not experience
any increase in hot flashes.
Raloxifene is known
as a SERM, a selective estrogen reuptake modulator. These are the so-called
"designer" estrogens - medications that act like a hormone in certain
areas of the body, such as the bones, while acting as an "anti-hormone"
in other areas, such as the breasts and uterus.
In this way, a SERM
can offer some of the same health benefits as estrogen with fewer risks,
says Dr. Steven Goldstein, a professor of obstetrics and gynecology
at New York University School of Medicine.
The finding, published
in the medical journal Obstetrics and Gynecology, is
also the first to document that once discontinuing hormone replacement
therapy (HRT), the peak recurrence of hot flashes can be expected at
approximately eight weeks, rather than four.
"This study is important
because drugs similar to Raloxifene have been shown to increase hot
flashes and, in fact, at least one never came to market because of this
problem," says Dr. Goldstein.
One of the downsides
of SERMS has been a tendency to increase hot flashes. This can be a
problem for women wanting to get off HRT and take this alternative approach
to bone health.
"What this study
told us is that you can stop taking HRT on a Sunday and start taking
Raloxifene on a Monday and it won't cause you to have any more hot flashes
than you might otherwise have when stopping HRT," Dr. Goldstein says.
Hot
Flashes a Fact of Life for Many Women
It is important
to note, however, that most women who do stop HRT experience a return
of at least some hot flash activity. All the new study is saying is
the introduction of Raloxifene into the regimen will not exacerbate
the problem, Dr. Goldstein adds.
Health experts say
the second finding - that hot flashes peak at about eight weeks rather
than four after stopping HRT - is also important.
The study authors
suggest the commonly used "washout" period at four weeks - when HRT
doses are slowly tapered off - may not be relevant because symptoms
will not peak until eight weeks.
Dr. Goldstein believes,
however, that if the tapering is gradual enough and the dosages of HRT
carefully monitored, the incidence of hot flashes can be controlled.
The study involved
266 women who had been taking HRT for at least five months. Each woman
was assigned to take one of the following treatments for 12 weeks: HRT;
a placebo (an inactive substance); HRT for four weeks, followed by Raloxifene
for eight weeks; or Raloxifene alone.
This initial treatment
was followed by 36 weeks of Raloxifene-only therapy for all the women.
The result: Raloxifene
did not appear to increase the risk of hot flashes over and above a
placebo, when used after discontinuation of HRT.
Second
Study Rules Out Urinary Incontinence
In another study
of Raloxifene, also published in Obstetrics and Gynecology,
a different group of physicians found the drug did not increase
the risk of urinary incontinence, even after three years of treatment.
This research involved
nearly 1,000 women at 10 sites across the US. All of them were at least
two years past menopause and diagnosed with osteoporosis.
Each of the women
filled out a questionnaire at the start of the study detailing, among
other things, any incidence of incontinence. They were then assigned
to take either a placebo or Raloxifene for three years. At the conclusion
they were once again questioned on the same topics.
The result: The
use of Raloxifene did not worsen any incontinence problems already present.
And it did not bring on the condition in those who did not experience
it before.
Eli Lilly and Co.,
the maker of Raloxifene, supported the two studies reported.
Always consult your
physician for a diagnosis.
Talking
With Your Healthcare Provider
The National
Women's Health Information Center provides the following tips
on questions to ask:
Make a list of concerns
and questions to take to your visit with your healthcare provider. While
you're waiting to be seen, use the time to review your list and organize
your thoughts.
Describe your symptoms
clearly and briefly. Say when they started, how they make you feel,
what triggers them, and what you have done to relieve them.
Tell your healthcare
provider what prescription and over-the-counter medicines, vitamins,
herbal products, and other supplements you're taking. Be honest about
your diet, physical activity, smoking, alcohol or drug use, and sexual
history - withholding information can be harmful. Describe allergies
to drugs, foods, or other things. Do not forget to mention if you
are being treated by other healthcare providers.
Do not feel
embarrassed about discussing sensitive topics. Do not leave something
out because you are worried about taking up too much time. Be sure
to have all of your concerns addressed before you leave.
If tests are ordered,
be sure to ask how to find out about results and how long it takes to
get them. Get instructions for what you need to do to get ready for
the test(s) and find out about any risks or side effects with the
test(s).
When you are given
medication and other treatments, ask your healthcare provider about
them. Talk about the latest studies and recommendations for treating
menopausal symptoms. Ask how long treatment will last, if it has any
side effects, how much it will cost, and if it is covered by insurance.
Make sure you understand how to take your medications; what to do if
you miss a dose; if there are any foods, drugs, or activities you should
avoid when taking the medicine; and if there is a generic brand available
at a lower price (you can also ask your pharmacist about this).
Understand everything
before you leave your visit. If you do not understand something,
ask to have it explained again.
Bring a family member
or trusted friend with you to your visit. That person can take notes,
offer moral support, and help you remember what was discussed. You can
also have that person ask questions as well.
Online
Resources
American
College of Obstetricians and Gynecologists
Centers
for Disease Control and Prevention (CDC)
HealthierUS.Gov
National
Institutes of Health (NIH)
National
Women's Health Information Center
Office
of Research on Women's Health
|
March 2004
Bone-Enhancing
Raloxifene Does Not Increase "Hot Flashes"
Hot
Flashes a Fact of Life for Many Women
Second
Study Rules Out Urinary Incontinence
Talking
With Your Healthcare Provider Menopause
Defined
Online
Resources
Other
Resources:
Find
a St. John's Mercy Physician
Women's
Services at St. John's Mercy
Women's
Health Information
St.
John's Mercy Classes and Programs
Menopause
Defined
When a woman permanently stops having menstrual periods,
she has reached the stage of life called menopause.
Often called the "change of life," this stage signals
the end of a woman's ability to have children.
Many physicians actually use the term menopause to refer
to the period of time when a woman's hormone levels begin to change.
Menopause is said to be complete when menstrual periods have ceased
for one continuous year.
The transition phase before menopause is medically referred
to as climacteric, but more recently has also been called perimenopause.
During this transition time before menopause, the supply
of mature eggs in a woman's ovaries diminishes and ovulation becomes
irregular.
At the same time, the production of estrogen and progesterone
decreases. It is the enormous drop in estrogen levels that causes most
of the symptoms commonly associated with menopause.
While the average age of menopause is 51, menopause
can actually occur any time between the ages of 40 and 55. Women who
smoke and are underweight tend to experience an earlier menopause, while
women who are overweight often experience a later menopause. Generally,
a woman tends to experience menopause at about the same age as her mother
did.
Menopause can also occur for reasons other than natural
reasons. These include, but are not limited to, the following:
-
premature menopause
Premature menopause may occur when there is ovarian failure before
the age of 40, and may be associated with smoking, radiation exposure,
chemotherapeutic drugs, or surgery that impairs the ovarian blood
supply.
-
surgical menopause
Surgical menopause may follow an oophorectomy (removal of an ovary
or both ovaries), or radiation of the pelvis, including the ovaries,
in premenopausal women. This results in an abrupt menopause, with
women often experiencing more severe menopausal symptoms than if
they were to experience menopause naturally.
Each woman may experience symptoms differently - with
some having few and less severe symptoms, while others have more frequent
and stressful ones.
Hot flashes are, by far, the most common symptom of
menopause, with about 75 percent of all women experiencing sudden, brief,
periodic increases in their body temperature.
Usually hot flashes start before a woman's last period.
For 80 percent of women, hot flashes occur for two years or less.
A small percentage of women experience hot flashes for
more than two years. These flashes seem to be directly related to decreasing
levels of estrogen.
Hot flashes vary in frequency and intensity for each
woman.
In addition to the increase in the temperature of the skin, a hot flash
may cause an increase in a woman's heart rate.
This causes sudden perspiration as the body tries to
reduce its temperature. This symptom may also be accompanied by heart
palpitations and dizziness.
Hot flashes that occur at night are called night sweats.
A woman may wake up drenched in sweat and have to change her night clothes
and sheets.
Vaginal atrophy involves the drying and thinning of the tissues of the
vagina and urethra.
This can lead to dyspareunia (pain during sexual intercourse),
as well as vaginitis, cystitis, and urinary tract infections.
Relaxation of the pelvic muscles can lead to urinary
incontinence and also increase the risk of the uterus, bladder, urethra,
or rectum protruding into the vagina.
Intermittent dizziness, paresthesias (an abnormal sensation
such as numbness, prickling, tingling, and/or heightened sensitivity),
cardiac palpitations, and tachycardia may occur as symptoms of menopause.
Changing hormones can cause some women to experience
an increase in facial hair and/or a thinning of the hair on the scalp.
While it is commonly thought that mental health may
be negatively affected by menopause, several studies have indicated
that menopausal women suffer no more anxiety, depression, anger, nervousness,
or feelings of stress than women of the same age who are still menstruating.
Psychological and emotional symptoms of fatigue, irritability,
insomnia, and nervousness may be related to both the lack of estrogen,
the stress of aging, and a woman's changing roles.
Always consult your physician for more information.
|